• PRODUCT PIPELINE

PRODUCT PIPELINE

RESEARCH

 

Regulators and medical professionals globally are recognising the range of disease indications with which medical cannabis is assisting.  Zelda Therapeutics understands the importance of expanding and improving the quality of cannabis research efforts to provide conclusive evidence of the efficacy of medical cannabis in treating various medical conditions.

Zelda has a clear pipeline of pre-clinical and clinical research activities, addressing some key research gaps and unmet market needs.  Zelda has gathered significant evidence in its pre-clinical cancer and diabetes research activities and has also initiated robust clinical trials in insomnia and autism.